Tim J. Dalebout
Leiden, ZH, Netherlands
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 14 publications
A design principle for tuning far-red absorption of chlorophyll a in light-harvesting complexes.
Journal: Communications chemistry
Published: January 16, 2026
Engineering potent live attenuated coronavirus vaccines by targeted inactivation of the immune evasive viral deubiquitinase.
Journal: Nature communications
Published: August 02, 2022
A Yellow Fever 17D Virus Replicon-Based Vaccine Platform for Emerging Coronaviruses.
Journal: Vaccines
Published: September 01, 2021
Prolonged activation of nasal immune cell populations and development of tissue-resident SARS-CoV-2-specific CD8+ T cell responses following COVID-19.
Journal: Nature immunology
Published: April 19, 2021
Immunogenicity and efficacy of one and two doses of Ad26.COV2.S COVID vaccine in adult and aged NHP.
Immunogenicity and efficacy of one and two doses of Ad26.COV2.S COVID vaccine in adult and aged NHP.
Journal: The Journal of experimental medicine
Published: December 31, 2020
Xrn1-resistant RNA structures are well-conserved within the genus flavivirus.
Journal: RNA biology
Published: October 16, 2020
Ad26 vector-based COVID-19 vaccine encoding a prefusion-stabilized SARS-CoV-2 Spike immunogen induces potent humoral and cellular immune responses.
Journal: NPJ vaccines
Published: July 30, 2020
SARS-coronavirus-2 replication in Vero E6 cells: replication kinetics, rapid adaptation and cytopathology.
Journal: The Journal of general virology
Published: June 23, 2020
Potent and selective inhibition of pathogenic viruses by engineered ubiquitin variants.
Journal: PLoS pathogens
Published: January 25, 2017
Last Updated: 09/26/2026